Penneo (PENNEO) Q2 2024 earnings summary

Executive summary

• ARR grew 23% year-over-year to 91.3M DKK, driven by strong new business, especially in Belgium, but uplift was historically low due to temporary downgrades and currency headwinds.

• EBITDA improved to -3.7M DKK from -6.6M DKK in Q1-2023, aligning with expectations and reflecting cost management and operational efficiency.

• 206 new customers were onboarded in Q1-2024, up 86% from Q1-2023, with 73% of new business ARR from foreign markets.

• Workforce reduced from 121 to 110 to support cash-positive goals while maintaining growth investments.

Financial highlights

• Revenue increased 17% year-over-year to 21.2M DKK; gross profit margin slightly decreased to 82% from 84%.

• ARR net retention rate was 107% for the 12-month period, with 13% uplift and 5% churn.

• Free cash flow was -7.3M DKK in Q1-2024; cash and cash equivalents at quarter-end were 34.0M DKK.

• Cash flow from operating activities was -0.7M DKK, impacted by seasonal revenue dip and deferred tax repayment.

• Staff costs remained stable, but capitalized staff costs rose 31% due to increased product development focus.

Outlook and guidance

• ARR guidance for 2024 is 105–112M DKK, implying 18–25% growth; EBITDA guidance is 5–10M DKK.

• Continued high demand expected due to AML legislation and digitalization, but cautious buying behavior persists.

• Plans to leverage Belgian momentum and enter Germany, with limited initial revenue assumed from Germany.

• Targeting cash-neutral or positive position by 2025 as ARR is expected to exceed cost base by end of 2024.